Study of Recombinant Factor IX Fc Fusion Protein (rFIXFc) in Participants With Hemophilia B
- First Posted Date
- 2009-12-07
- Last Posted Date
- 2020-12-19
- Lead Sponsor
- Bioverativ Therapeutics Inc.
- Target Recruit Count
- 123
- Registration Number
- NCT01027364
- Locations
- 🇨🇳
Research site, Beijing, China
🇬🇧Research Site, London, United Kingdom
🇯🇵Ressearch Site, Suginami-ku, Japan
Phase I/IIa Study of FIXFc in Hemophilia B Patients
- First Posted Date
- 2008-07-16
- Last Posted Date
- 2020-12-19
- Lead Sponsor
- Bioverativ Therapeutics Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT00716716
- Locations
- 🇺🇸
Puget Sound Blood Center, Seattle, Washington, United States
🇺🇸Brigham & Women's Hospital, Boston, Massachusetts, United States
🇺🇸Hemophilia Center of Western PA, Pittsburgh, Pennsylvania, United States
© Copyright 2025. All Rights Reserved by MedPath